All filters
E-Posters
Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 Isolates
A. Giannini
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina Cohort
N. Lübke
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Transmitted Drug Resistance To Integrase Based First-Line HIV Antiretroviral Treatment In The MeditRes HIV Collaboration
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dynamics Of HIV-1 Transmission Clusters In North And Central Italy Over The Years 2012-2019
R. Scutari
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Exploring Molecular Characteristics And Evolutionary Dynamics Of The HIV-1 Epidemic In Montenegro Through Phylogenetic Analyses
S. Dragas
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence And Spatiotemporal Dynamics Of The HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) In The Former Soviet Union
E. Ozhmegova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Short- And Long-Term Direct Medical Costs Of Late And Very Late HIV Presentation
L. Versteegh
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Cabotegravir + Rilpivirine Every 2 Months Is Noninferior To Monthly: ATLAS-2M Study
P. Benn
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Treatment Outcome Among People Living With Hiv Starting First-Line Rapid Or GRT Guided ART From 2015 To 2018
A. De Vito
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Evaluation Of HIV-1 Tropism In Multidrug-Resistant cART Failing Patients
Y. Bouba
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Assessment Of Genotypic Patterns Associated With HIV-1 Sensitivity To Ibalizumab
H. Jullien
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
DTG+3TC vs DTG+TDF/FTC (GEMINI1&2): Confirmed Virologic Withdrawals Through Week 96
J. Van Wyk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Role Of Analitical Treatment Interruption On HIV Peripheral Reservoir Diversification
C. Alteri
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
In Vitro Activity Of Islatravir Against HIV-1 Mutants Harboring Multiple NRTI Resistance Mutations
F. Giammarino
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Similar Levels Of HIV-Dna And Residual Viremia Are Found In Virologically Suppressed Individuals Who Continue A Two-Drug Regimen With Dolutegravir Plus One Reverse Transcriptase Inhibitor Or Switch To Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafen
M. M. Santoro
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Case Report: Poor Adherence To Dolutegravir Is Associated With Selection Of Resistance Mutations T66I, G118R, E138A And L74I
M. Pauskar
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Multicentric Castleman Disease HHV-8 Related In A HIV Patient
A. Gjataj
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV Seronegativity After Rapid Art: A Case Demonstrating Future Challenges In HIV Confirmation Testing In The Era Of iART
K. Yan
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Variability In HIV Proviral DNA Genotyping Results From A Single Blood Draw
R. Acosta
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Virological Efficacy And Resistance Evaluation In People Living With HIV Starting An STR Regimen
G. Stella
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Resistant Minority Variants Observed In Failing Patients At Week 48 In Anrs 170 Quatuor Trial (A 4/7 Days Maintenance Strategy Vs A 7/7 Days Regimen In Patients With Controlled Viral Load)
S. Lambert
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Molecular Characterization In Hcv Late Relapser Patients Treated With Direct-Acting Antiviral (DAA) Drugs
M. Rueca
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Clinical And Virological Characteristics And Retreatment Of Patients With Chronic Hepatitis C Virus Infection And Failure To Sofosbuvir, Velapatasvir, And Voxilaprevir In Real-World
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Pharmaco-Virological Algorithm To Target Risk Of Resistance Among A Population Of HIV-Infected Female Sex Workers In Togo
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020